Actinium Pharmaceuticals Files 2024 Annual Report
Ticker: ATNM · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1388320
| Field | Detail |
|---|---|
| Company | Actinium Pharmaceuticals, Inc. (ATNM) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Actinium Pharma filed its 2024 10-K. All systems go.
AI Summary
Actinium Pharmaceuticals, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, incorporated in Delaware and headquartered at 100 Park Ave., New York, NY, operates in the pharmaceutical preparations sector. The filing covers the period ending December 31, 2024, and was submitted on March 31, 2025.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Actinium Pharmaceuticals' financial performance and business operations for the fiscal year 2024.
Risk Assessment
Risk Level: low — This is a standard annual report filing and does not contain new material information that would inherently increase risk.
Key Numbers
- 2024 — Fiscal Year End (The report covers the financial performance up to this date.)
- 20250331 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- Actinium Pharmaceuticals, Inc. (company) — Registrant
- December 31, 2024 (date) — Fiscal year end
- March 31, 2025 (date) — Filing date
- 100 Park Ave., 23rd Floor New York, NY 10017 (address) — Principal executive offices
- 001-36374 (other) — Commission file number
FAQ
What is the primary business of Actinium Pharmaceuticals, Inc.?
Actinium Pharmaceuticals, Inc. is primarily involved in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification code [2834].
Where are Actinium Pharmaceuticals, Inc.'s principal executive offices located?
The company's principal executive offices are located at 100 Park Ave., 23rd Floor, New York, NY 10017.
What is the commission file number for Actinium Pharmaceuticals, Inc.?
The commission file number for Actinium Pharmaceuticals, Inc. is 001-36374.
In which state was Actinium Pharmaceuticals, Inc. incorporated?
Actinium Pharmaceuticals, Inc. was incorporated in Delaware.
What is the fiscal year end for Actinium Pharmaceuticals, Inc.?
The fiscal year end for Actinium Pharmaceuticals, Inc. is December 31.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Actinium Pharmaceuticals, Inc. (ATNM).